Immune Pharmaceuticals, Inc. (NASDAQ: IMNP), headquartered in New York City, applies a personalized,bio-marker based approach to treating inflammatory diseases
and cancer . . .
The 2015 Marcum Microcap Conference
Date: Thursday, May 28, 2015
Location: Grand Hyatt NYC, NY, Uris room
IMMUNE is focused on developing the next generation of monoclonal antibodies to
address significant unmet medical needs in
the treatment of cancer and inflammatory diseases. Our goal is to improve patients’ lives through targeted medicine.
Immune Pharmaceuticals Inc. [IMNP]
NASDAQ Closing Bell Ceremony
May 26, 2015
Time: 3:45 PM (begins)
See More Events